A German medical device and services company agreed to settle charges of violating the anti-bribery, books and records, and internal accounting controls provisions of the Foreign Corrupt Practices Act.
A U.S. company agreed to settle SEC charges for violating the Foreign Corrupt Practices Act. Separately, the DOJ announced the indictment of two of the company's former executives for violating the Act's anti-bribery and accounting provisions.
A Brazilian oil and gas company agreed to settle DOJ and SEC charges concerning the misrepresentation "of assets, infrastructure projects . . . and the nature of its relationships with its majority shareholder, the Brazilian government."